US rice found to have high levels of arsenic, cadmium
[Source]
New testing reveals that virtually all rice sold in the U.S. contains arsenic and cadmium, with one-fourth of samples exceeding federal safety limits established for infant rice cereal.
Key findings: Tests of 145 rice samples from retailers nationwide detected arsenic — a highly toxic metalloid — in 100% of samples, with more than one in four exceeding the FDA's 100 parts-per-billion limit set for infant rice cereal in 2021. California-grown rice had the lowest overall heavy metal content at 65 parts per billion, while U.S.-grown brown rice contained the highest at 151 parts per billion.
Cadmium, a highly toxic heavy metal, was also found in all but one sample, with higher concentrations in Indian basmati and Italian Arborio varieties. Tests of 66 samples of alternative grains like barley, couscous, farro and quinoa showed significantly lower levels of these toxic metals, with overall levels three times lower than rice.
Dangers: Jane Houlihan, the national director of science and health at Healthy Babies, Bright Futures — which produced the report — said parents should not have to worry that a common first food such as rice could pose hidden risks. 'Even at low levels, both arsenic and cadmium have been linked to serious health harms, including diabetes, developmental delays, reproductive toxicity and heart disease,' she told CNN.
Trending on NextShark:
What you can do: Rice accounts for 54.5% of arsenic exposure in diets of Asian children between 18 and 24 months, the tests found. To reduce exposure by up to 60%, families are encouraged to cook rice like pasta, using six to 10 cups of water per cup of rice and draining the excess before eating. Simply rinsing rice before cooking does not work, but soaking rice for a half hour or overnight before cooking further reduces contamination levels. '
Parents can also choose lower-risk varieties like California-grown, Thai jasmine or Indian basmati rice and incorporate alternative grains with lower metal content. Additionally, consuming foods rich in B vitamins, vitamin C, calcium, iron and zinc can help reduce the body's absorption of contaminants or speed up their excretion.
The findings come as research shows climate change could worsen the problem, with a Columbia University-led study finding that projected 2050 temperature and CO₂ levels could significantly increase inorganic arsenic in rice.
Trending on NextShark:
This story is part of The Rebel Yellow Newsletter — a bold weekly newsletter from the creators of NextShark, reclaiming our stories and celebrating Asian American voices.
Subscribe free to join the movement. If you love what we're building, consider becoming a paid member — your support helps us grow our team, investigate impactful stories, and uplift our community.
Trending on NextShark:
Subscribe here now!
Download the NextShark App:
Want to keep up to date on Asian American News? Download the NextShark App today!
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time Business News
42 minutes ago
- Time Business News
Online News Spotlight: Global Vape Kit Policy Changes Shaping the Future of Vaping
The global landscape of vaping regulations is shifting rapidly as governments and health authorities respond to rising concerns over youth vaping, product safety, and public health implications. In recent months, online news platforms have been abuzz with updates about vape kit policy changes in various parts of the world. These updates are shaping consumer behavior, impacting manufacturers, and drawing strong reactions from advocacy groups and health officials alike. In this blog, we'll explore the major policy shifts making headlines across continents, the motivations behind these changes, and the broader implications for the vaping industry. In today's world, ensuring access to pure and safe drinking water is essential for health and well-being. Modern filtration technology has made it easier to remove contaminants and improve water quality effectively. Among the latest innovations, the hayati pro ultra 25000 stands out for its high efficiency and reliability. Designed to handle large volumes of water, it combines advanced filtration methods to eliminate impurities and harmful substances. This system not only provides clean water but also supports sustainable usage with durable components. Perfect for both residential and commercial settings, it represents a significant step forward in water purification technology. In the United States, the Food and Drug Administration (FDA) has intensified its crackdown on unauthorized vape products. Following the ongoing scrutiny over flavored e-cigarettes and their role in youth vaping epidemics, the FDA has issued warning letters to several manufacturers and retailers. Recent online reports highlight that the agency is actively seeking to remove from the market all vape kits that haven't undergone its premarket tobacco product application (PMTA) process. In particular, the FDA is targeting disposables and fruit-flavored products that are appealing to minors. The heightened regulation has triggered widespread debate. Public health experts support the move, citing concerns over increasing teen nicotine addiction. On the other hand, adult users and harm reduction advocates argue that overregulation may inadvertently push people back to smoking traditional cigarettes. News outlets covering these stories emphasize the delicate balance regulators must strike between protecting youth and supporting smokers trying to quit through vaping. Across the Atlantic, the UK government is planning to introduce a new vape tax as part of its broader anti-smoking strategy. According to online reports from major British media outlets, the proposed legislation includes restrictions on vape flavors, packaging designs, and a new excise tax on vape liquids. The move has sparked a wave of public feedback and concern among vaping communities, particularly because the UK has traditionally been more vape-friendly compared to other nations. British health authorities have promoted vaping as a smoking cessation tool for years. However, rising rates of youth experimentation and illegal sales of high-nicotine devices have forced the government to reconsider its approach. Online news articles highlight how the proposed policies aim to reduce underage access while maintaining support for adult smokers. Still, critics warn that heavy-handed measures could erode public trust and damage one of the country's most successful harm reduction strategies. Australia continues to lead with one of the strictest vaping policies globally. As of recent updates, vape kits containing nicotine can only be accessed through a doctor's prescription. This policy has been in place for a while, but online news platforms report that enforcement has intensified in 2025. Border seizures of illegal vape imports have increased, and authorities are cracking down on retailers violating the rules. Online media coverage from Australian health officials points to youth protection and addiction prevention as the primary goals. However, public health advocates and medical professionals remain divided. Some argue that restricted access is crucial to curbing rising youth vaping rates, while others say it places unnecessary burdens on adults seeking safer alternatives to smoking. Online discussions often focus on how the black market is thriving under the current framework, undermining the policy's original intent. New Zealand's vaping policy has traditionally favored a balanced, harm-reduction approach. However, online news sources reveal that the government is now reviewing its regulatory stance in light of growing public health concerns. Changes being considered include limiting the types of vape flavors allowed, enforcing stricter advertising rules, and introducing tougher penalties for retailers who sell to minors. Health officials in New Zealand still support vaping as a tool to help people quit smoking, a position echoed by many online editorials and expert interviews. However, policymakers are now more cautious, especially given data suggesting a rise in youth vaping prevalence. The upcoming policy review is expected to incorporate insights from both public health research and community consultations. The European Union is witnessing a patchwork of vape regulations across its 27 member countries. Online news outlets are closely monitoring efforts by the European Commission to update the Tobacco Products Directive (TPD), which governs the sale and marketing of vape products. New proposals are expected to address nicotine limits, product labeling, cross-border sales, and environmental concerns related to disposable devices. EU-based news coverage indicates a strong push from health NGOs to introduce plain packaging and flavor bans, particularly for fruity and sweet vape kits. However, industry voices are cautioning against policies that might stifle innovation or limit access to potentially life-saving alternatives. The conversation online also includes growing concern about illicit trade and how uneven enforcement across member states can compromise regulatory goals. In Canada, several provinces have moved ahead with their own flavor bans, sparking nationwide discussion. Online news reports confirm that provinces like British Columbia and Nova Scotia have restricted or banned the sale of flavored vape products, citing their appeal to young users. Health Canada is also reportedly considering national regulations to align with these provincial measures. Online media commentary shows a growing divide between federal and provincial policies, with some stakeholders calling for a more unified approach. Youth vaping statistics have been central to the debate, and public reactions vary widely. Some applaud the bans as a necessary step, while others argue they could reduce smoking cessation success rates. The story continues to evolve as lawmakers seek a compromise that supports both public health and adult smokers. The vaping regulatory environment in Asia is highly diverse, as highlighted by various online news platforms. Countries like Japan and South Korea have adopted relatively permissive policies toward heat-not-burn tobacco products but remain cautious about nicotine vapes. Meanwhile, nations such as India and Thailand have implemented outright bans on e-cigarettes, citing public health risks and lack of long-term safety data. In China, the world's largest manufacturer of vape products, the government has introduced strict new rules governing product standards, marketing, and domestic sales. Online coverage reveals that these changes are intended to align the vape industry with traditional tobacco controls, a move that significantly affects global supply chains. The Asian market's varied regulatory stances continue to influence how international companies navigate compliance and innovation. Across the globe, the vaping industry is grappling with the implications of these policy shifts. Online news reports frequently cover how manufacturers are adjusting product lines, reformulating flavors, and investing in compliance infrastructure. Meanwhile, consumers are expressing frustration over reduced access to preferred products and confusion about new laws. Some online stories spotlight the rise of advocacy groups pushing back against restrictive measures, arguing for evidence-based policies that prioritize harm reduction. Others focus on the booming black market and how regulatory gaps are being exploited. For consumers, especially those using vaping as a smoking cessation aid, these changes can mean fewer choices and more uncertainty. As online news coverage illustrates, vape kit policy changes are unfolding rapidly across the world, reflecting broader societal tensions between innovation, public health, and personal freedom. Governments are increasingly walking a tightrope—balancing the need to protect youth while enabling smokers to access less harmful alternatives. Whether through outright bans, strict regulation, or supportive harm-reduction models, the direction of policy will continue to evolve in response to public opinion, emerging science, and industry developments. For vape users, manufacturers, and policymakers alike, staying informed through credible news sources is essential. The future of vaping remains uncertain, but one thing is clear: the global regulatory landscape will continue to be a hotbed of debate, transformation, and innovation in the months and years ahead. TIME BUSINESS NEWS
Yahoo
an hour ago
- Yahoo
DIA to Celebrate 9 Life Sciences Leaders at DIA 2025 Global Annual Meeting in Washington
EMA's Emer Cooke, former FDA Commissioner Dr. Robert Califf to be recognized among new Fellows of DIA and annual Global Inspire Award winners, with special keynote from global health leader Dr. Larry Brilliant and live performance from Grammy-nominated artist Aloe Blacc WASHINGTON, June 04, 2025--(BUSINESS WIRE)--DIA, a global non-profit organization of life sciences professionals, will induct four Fellows of DIA and recognize six recipients of Global Inspire Awards and America's Inspire Awards on June 15 as part of the DIA 2025 Global Annual Meeting — including Emer Cooke, Executive Director of the European Medicines Agency (EMA), who is receiving both honors. Fellows of DIA are long-serving members recognized for their sustained dedication to advancing healthcare. The Global Inspire Awards recognize honorees who have made outstanding improvements to global health while adhering to DIA's mission. "These distinguished individuals have made enduring contributions to the life sciences reflecting DIA's values and purpose," said Marwan Fathallah, DIA's President and Chief Executive Officer. "Their work in regulatory science, research, and global collaboration exemplifies the spirit of innovation that drives our mission forward." Cooke has been the EMA's Executive Director and the Chair of the International Coalition of Medicines Regulatory Authorities (ICMRA) since November 2020. She has more than 30 years of experience in international regulatory affairs, including four years as the director responsible for medical product-related regulatory activities at the World Health Organization (WHO). Dr. Robert M. Califf, who served as the Commissioner of the U.S. Food and Drug Administration (FDA) from February 2016 to January 2017 and February 2022 to January 2025, is also being recognized as a Fellow of DIA. A nationally recognized expert in cardiovascular medicine and health outcomes research, he has led many landmark clinical trials and is one of the most frequently cited authors in biomedical science. Dr. Califf became a Member of the National Academy of Medicine in 2016. Dr. Michael Rosenblatt and Dr. Hironobu Saito are also being named Fellows of DIA. Rosenblatt, a Senior Partner at Flagship Pioneering and the Immediate Past Chair of DIA's Board of Directors, has advanced biopharmaceutical research and development throughout his career. He was previously Merck's Chief Medical Officer and the Dean of the Tufts University School of Medicine. Saito, a Specially Appointed Professor at Tottori University's Chromosome Engineering Research Center, spent 35 years in drug development at Daiichi Sankyo and has contributed to DIA Japan for more than two decades. In addition to Cooke, who will be presented with the Global Award for Outstanding Contribution to Health, six members of the health and life sciences community will receive Global Inspire Awards: — Kazumichi Kobayashi, Executive Deputy President at Otsuka Medical Device, will be honored with the Global Connector Award for advancing DIA's mission and promoting global collaborations. Kobayashi, who has served in various senior positions in research and development at Otsuka Pharmaceutical Co., previously led DIA Japan and chaired the DIA Advisory Council of Japan. — Cary Smithson will receive the Community Engagement Award as a DIA Community Chair who consistently drives engagement while advancing knowledge and thought leadership. Smithson, a Managing Partner at LeapAhead Solutions, leads DIA's Regulatory Affairs Community and Regulatory Information Management (RIM) Intelligent Automation Team, and co-leads its RIM Working Group. —Jennifer B. Christian will be named the Author of the Year, an award given to individuals whose article made the greatest impact on readership based on the number of downloads reported by Therapeutic Innovation & Regulatory Science (TIRS) in the preceding issue year. Her article, co-authored with Mehmet Burcu, Cyntia B. Manzano-Salgado, Anne M. Butler, "A Framework for Extension Studies Using Real-World Data to Examine Long-Term Safety and Effectiveness," was downloaded more than 12,400 times. Global Inspire Award recipients, except for the Author of the Year, must be nominated by two active DIA members to be considered candidates. They undergo a thorough review process before a committee of Fellows of DIA selects the winners. DIA will also recognize the regional Inspire Awards winners from the Americas: — David Fryrear, Chief Quality Officer at Astellas Pharma, will receive the Excellence in Service Award as a DIA volunteer who has significantly contributed to the advancement of the organization's mission. He previously held senior roles at AbbVie and Eli Lilly and Company and spent much of his career developing and improving quality systems. — Elma Abdulbaki, a PharmD student at the University of Illinois at Chicago and President of the DIA National Student Board, will be honored with the Leader of Tomorrow Award for her outstanding contributions as a young professional in the healthcare field. In addition to these awards and recognitions, there will be a performance by Grammy-nominated artist and songwriter Aloe Blacc. Renowned physician, epidemiologist, and global health leader Dr. Larry Brilliant will keynote at the event. Tickets for the awards ceremony are available to the public for the first time and can be purchased by clicking here. These honors will be presented in conjunction with the DIA 2025 Global Annual Meeting, the world's preeminent multidisciplinary life sciences forum held June 15-19 at the Walter E. Washington Convention Center in Washington. Click here to register or view the DIA 2025 event program. Media members may request credentials by emailing diaglobal@ About DIADIA is a leading global non-profit life science membership association that drives collaboration in drug, device, and diagnostics development in pursuit of a healthier world. Founded in 1964 with headquarters in Washington, D.C., and offices in Europe and Asia, DIA provides unparalleled networking opportunities, educational resources, scientific research publications, and professional development programs to members in more than 80 countries. Learn more at and connect with DIA on LinkedIn, Facebook, X (Twitter), and Instagram. View source version on Contacts Media Katie KennedyGregory FCAdiaglobal@ 610-731-1045 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
CSI Pharmacy Secures California Non-Resident Permit, Achieving Nationwide Reach
Bringing Personalized Specialty Pharmacy Services to All 50 States NASHVILLE, Tenn., June 4, 2025 /PRNewswire/ -- CSI Pharmacy is proud to reveal that, as of May 13, 2025, it is officially licensed to serve patients in all 50 states with the approval of two non-resident California pharmacy permits. This milestone marks a major achievement in CSI Pharmacy's mission to deliver personalized, patient-centered specialty pharmacy care to individuals living with chronic and rare diseases. James Sheets, PharmD, CEO and Founder of CSI Pharmacy, shared his thoughts on the significance of this expansion: "Reaching all 50 states is more than a milestone for us — it's a reflection of our commitment to ensure patients receive the highest level of care and comfort. California is home to one of the most diverse patient populations in the country, and we're excited to deliver our compassionate, personalized care to communities that need it most. At CSI, we believe in 'individualized therapies designed to be as unique as you,' and we're proud to extend that promise to every corner of the nation." With licensure secured, CSI Pharmacy can begin serving California-based patients immediately. Several patient transfers are already in progress, and their team is prepared to onboard additional referrals. To meet growing demand, CSI Pharmacy will expand its team to support this new territory in the coming months. Additionally, CSI Pharmacy is exploring physical space options in the state as well. While this physical location is not required to serve patients, the future brick and mortar expansion represents the passion they hold to serve patients well and quickly. The new licenses not only emphasize CSI Pharmacy's nationwide capabilities, but it also highlights an ongoing commitment to access, equity, and personalized care across every community CSI Pharmacy serves. About CSI PharmacyCSI Pharmacy is a nationwide specialty infusion pharmacy focused on supporting patients with chronic and rare conditions through home-based immunoglobulin (IVIg and SCIg) therapies and other complex medications. The expert team works closely with providers, insurance groups, and advocacy organizations to ensure timely access to life-changing treatments with compassion, precision, and purpose. For more information, visit or contact info@ View original content to download multimedia: SOURCE CSI Pharmacy
